|
|
|
|
| Symbol(s): |
BRKR |
| Date: |
7-Feb-10 |
| Contributor: |
PriceTarget Research, Inc. |
| Title: |
Bruker has a current Overall Rating of A (Highest Rating). |
| Document Size: |
7 pages |
| Price: |
$25 |
| Document Type: |
Adobe Acrobat Reader®
Download free Adobe Acrobat Reader® |
|
| Research Reports Premium Services |
| ·
|
Get the full report for $25. |
| ·
|
You will have access to this report for 24 hours. |
|
|
|
|
|
| Bruker has a current Overall Rating of A (Highest Rating). Power Rating (83) is very high; appreciation potential (66) is high. Relative to the S&P 500 Composite, Bruker Corporation has moderate Growth characteristics -- its appeal is likely to be to Capital Gain-oriented investors. BRKR is of average investment quality. Current annual total return performance of -22.3% is lower quartile. Over the full time period, Bruker BioScience's stock price performance has been variable and...
| | |
|
|
